Back

American Society for Nutrition

  • Glucagon-Like Peptide-1 Receptor Agonists
  • Obesity
  • Weight Loss

Meeting the Nutritional Needs of Patients on Anti-Obesity Medications: What s New?

Recently developed anti-obesity medications have revolutionized obesity treatment with significant weight loss outcomes. This engaging session explores the vital nutritional considerations for individuals on these medications. Attendees will gain insights into the evaluation, management, and follow-up strategies that optimize nutritional care for patients with obesity, ensuring lasting success throughout their weight loss therapy. This session also includes a discussion of Nutritional Priorities to Support GLP-1 Therapy for Weight Loss: A Joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Originally presented at NUTRITION 2025, ASN’s flagship meeting which was held May 31 to June 3 in Orlando, FL. Learning Objectives: – Describe nutritional risks and body composition changes associated with GLP-1 RA obesity medications – Perform baseline assessments to guide individualized nutrition recommendations – Apply strategies to manage GI side effects and support adequate nutrient intake – Integrate physical activity and multidisciplinary support into obesity care

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

ASN Member price$10
Regular price$20

Listed by the provider · discover.nutrition.org

  • Enduring / On-demand
  • Credit · Up to 1.5 credits
  • $10 member · $20 standard
  • Released
    Aug 18, 2025
  • Last day to claim credit
    Sep 1, 2027 11 months left